Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ). Vondeling GT, Croda J, Jelinek T, Kassianos G, et al. Vaccine 2026;79:128491.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vondeling GT, Croda J, Jelinek T, Kassianos G, et al. Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ). Vaccine 2026;79:128491.
PMID: 41863914